Scientists peek inside lungs of ICU patients to fight pneumonia
NCT ID NCT07436780
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at certain immune cells (B lymphocytes) in the lungs of patients on breathing machines in the intensive care unit. The goal is to understand how these cells change in patients who develop pneumonia from the ventilator. 75 adults will take part, and researchers will collect samples from the breathing tube to analyze the cells.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 75 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2026
An estimate. Start dates often move.
- Expected to finish
-
Jul 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients of Limoges University Hospital admitted to emergency room
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adult patients (≥18 years old), admitted to intensive care under mechanical ventilation for an estimated duration of at least 5 days. Exclusion Criteria: * Patients admitted for an infectious pneumonia or presenting with acute respiratory distress syndrome (ARDS). Patients in aplasia (leukocytes \< 0.5 gigal/L).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Ventilator associated pneumonia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Europe's ICUs join forces to take on a deadly lung infection
- Fast lung test may help doctors pick the right antibiotic sooner
- Rethinking staff training to fight a deadly ICU infection
- Speedier lab test could curb superbug threat in ICU pneumonia
- Human milk mouth care may shield preemies from lung infections
- Could a 'robotic cough' stop deadly pneumonia in ICU patients?